Search Results - "Sayhan, N."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    P53 codon 72 genotypes in colon cancer. Association with human papillomavirus infection by Sayhan, N, Yazici, H, Budak, M, Bitisik, O, Dalay, N

    “…It has been reported that the p53Arg homozygous genotype could be a potential genetic risk factor for cancer. In this study we investigated the proportion of…”
    Get more information
    Journal Article
  2. 2

    ADP-ribosylation of human serum proteins promoted by endogenous NAD glycohydrolase activity by Nurten, R, Ustündağ, I, Sayhan, N, Bermek, E

    “…Incubation of human serum samples with [adenine-14C]NAD resulted in a time- and dose-dependent incorporation of adenine moiety into CCI3COOH-precipitable…”
    Get more information
    Journal Article
  3. 3

    Detection of t(14;18) in Turkish follicular lymphomas using the polymerase chain reaction by Sayhan, Nur, Tuzuner, Nukhet, Akı, Hilal, Demir, Gökhan, Berkarda, Bülent

    Published in Leukemia research (01-06-2000)
    “…A t(14;18) translocation is closely associated with the follicular lymphoma but is also seen in diffuse B cell lymphomas with a previous history of a…”
    Get full text
    Journal Article
  4. 4

    Thrombophilia and inflammatory bowel disease: does factor V mutation have a role? by Over, H H, Ulgen, S, Tuğlular, T, Tezel, A, Avşar, E, Geyik, G, Başgül, S, Sayhan, N, Ulusoy, N, Kalayci, C, Tözün, N

    “…An increased tendency for thromboembolism is a well known problem of inflammatory bowel disease (IBD). Microvascular thrombosis has also been claimed as a…”
    Get more information
    Journal Article
  5. 5

    Simultaneous presentation of hepatocellular carcinoma in identical twin brothers by Demir, Gokhan, Belentepe, Sedef, Ozguroglu, Mustafa, Celik, Aykut Ferhat, Sayhan, Nur, Tekin, Salim, Mandel, Nil Molinas, Buyukunal, Evin, Serdengecti, Suheyla

    “…Family history and hepatitis B virus (HBV) infection have been identified as risk factors for hepatocellular carcinoma. We report hepatocellular carcinoma…”
    Get full text
    Journal Article
  6. 6

    Immunomodulating therapy with rIL-2 and interferon alpha-induces in vivo expression of Bcl-2, Fas (APO-1/CD95), and Fas ligand on peripheral lymphocytes (a pilot study) by Demir, G, Ozguroglu, M, Sayhan, N, Molinas-Mandel, N, Demirelli, F, Buyukunal, E, Tuzuner, N, Serdengecti, S, Berkarda, B

    Published in Anticancer research (01-07-1999)
    “…The first Phase I Trial with a combination of IL-2 and IFN-alpha was published in 1989. There are still some questions though, concerning the in vivo effects…”
    Get more information
    Journal Article
  7. 7